93 results on '"Dembinski J."'
Search Results
52. The Cantrell-Sequence: A Result of Maternal Exposure to Aminopropionitriles?
- Author
-
Dembinski, J., primary, Heyl, W., additional, Steidel, K., additional, Hermanns, B., additional, Hörnchen, H., additional, and Schröder, W., additional
- Published
- 1997
- Full Text
- View/download PDF
53. Thyroid Function in Healthy and Sick Very-Low-Birth-Weight Infants - Thyrotropin and Free Thyroxine Levels until the Sixth Week of Age.
- Author
-
Dembinski, J., Arpe, V., Kroll, M., Bartmann, P., and Hieronimi, G.
- Published
- 2001
- Full Text
- View/download PDF
54. Effects of ganglion blocking agents on nicotine extensor convulsions and lethality in mice
- Author
-
ACETO, M. D., primary, BENTLEY, H. C., additional, and DEMBINSKI, J. R., additional
- Published
- 1969
- Full Text
- View/download PDF
55. Impact de la fermeture systématique de l’orifice de trocart épigastrique de 12mm sur le taux d’éventration après sleeve gastrectomie : une étude prospective avant/après
- Author
-
Rebibo, L., Demouron, M., Dembinski, J., Dhahri, A., Yzet, T., and Regimbeau, J.M.
- Abstract
Les éventrations sur orifice de trocarts (TSH) sont sous-estimées après chirurgie bariatrique. L’objectif était d’évaluer le taux de TSH après fermeture du trocart épigastrique (TE) après sleeve gastrectomie (SG).
- Published
- 2019
- Full Text
- View/download PDF
56. Thyroid function and adverse outcome--What is the message?
- Author
-
Dembinski J
- Published
- 1999
- Full Text
- View/download PDF
57. Laparoscopic spleen-preserving distal pancreatectomy with splenic vessels resection (laparoscopic Warshaw procedure)
- Author
-
J, Dembinski, R, Cannella, A, Sauvanet, S, Dokmak, Dembinski J., Cannella R., Sauvanet A., and Dokmak S.
- Subjects
Pancreatic Neoplasms ,Pancreatectomy ,Treatment Outcome ,Splenic Vein ,Abdomen ,Humans ,Laparoscopy ,General Medicine ,Splenic Artery ,Spleen ,Distal pancreatectomy, Warshaw technique, Laparoscopic, Minimally invasive, Splenic vessels resection - Published
- 2022
58. Low-temperature catalytic hydrogenolysis of hydrocarbons to methane. [over promoted Ni--Al/sub 2/O/sub 3/ or Ni--SiO/sub 2/ catalysts]
- Author
-
Dembinski, J
- Published
- 1969
59. Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease.
- Author
-
Sissoko A, Cissé A, Duverdier C, Marin M, Dumas L, Manceau S, Maître B, Eckly A, Fricot-Monsinjon A, Roussel C, Ndour PA, Dussiot M, Dokmak S, Aussilhou B, Dembinski J, Sauvanet A, Paye F, Lesurtel M, Cros J, Wendum D, Tichit M, Hardy D, Capito C, Allali S, and Buffet P
- Abstract
In children with sickle cell disease (SCD), splenectomy is immediately beneficial for acute sequestration crises and hypersplenism (ASSC/HyS) but portends a long-term risk of asplenia-related complications. We retrieved peripheral and splenic red blood cells (RBCs) from 17 SCD children/teenagers undergoing partial splenectomy for ASSC/HyS, 12 adult subjects without RBC-related disease undergoing splenectomy (controls), five human spleens perfused ex vivo with Hb
SS - and HbAA -RBC, and quantified abnormal RBC by microscopy, spleen-mimetic RBC filtration, and adhesion assays. Spleens were analyzed by immunohistochemistry and transmission electron microscopy (TEM). In circulating blood of SCD and control subjects, dysmorphic (elongated/spherocytic) RBCs were <2%, while proportions of pocked-RBC were 4.3-fold higher in SCD children than in controls. Compared to controls, splenic RBCs were more frequently dysmorphic (29.3% vs. 0.4%), stiffer (42.2% vs. 12.4%), and adherent (206 vs. 22 adherent RBC/area) in SCD subjects. By TEM, both polymer-containing and homogenous RBC contributed to spleen congestion, resulting in 3.8-fold higher RBC population density in SCD spleens than in control spleens, predominantly in the cords. Perfused spleens with normal function displayed similar congestion and retention of dysmorphic RBC as SCD spleens. The population density of active macrophages was similar in SCD and control spleens, with a relative deficit in phagocytosis of polymer-containing RBC. Despite the existence of hyposplenism, splenectomy in SCD children removes an organ that still efficiently filters out potentially pathogenic altered RBC. Innovative treatments allowing fine-tuned reduction of RBC retention would alleviate spleen congestion, the major pathogenic process in ASSC/HyS, while preserving spleen protective functions for the future., (© 2024 The Author(s). American Journal of Hematology published by Wiley Periodicals LLC.)- Published
- 2024
- Full Text
- View/download PDF
60. Retromesenteric omental flap as arterial coverage in pancreaticoduodenectomy: A novel technique to prevent postpancreatectomy hemorrhage.
- Author
-
Marique L, Codjia T, Dembinski J, Dokmak S, Aussilhou B, Jehaes F, Cauchy F, Lesurtel M, and Sauvanet A
- Subjects
- Humans, Female, Male, Retrospective Studies, Middle Aged, Aged, Adult, Pancreatic Neoplasms surgery, Postoperative Complications prevention & control, Postoperative Complications epidemiology, Postoperative Complications etiology, Treatment Outcome, Pancreaticoduodenectomy adverse effects, Pancreaticoduodenectomy methods, Postoperative Hemorrhage prevention & control, Postoperative Hemorrhage etiology, Omentum transplantation, Omentum surgery, Surgical Flaps transplantation, Surgical Flaps blood supply, Surgical Flaps adverse effects, Pancreatic Fistula prevention & control, Pancreatic Fistula etiology, Pancreatic Fistula epidemiology
- Abstract
Background: Clinically relevant postpancreatectomy hemorrhage occurs in 10% to 15% of patients after pancreaticoduodenectomy, mainly in association with clinically relevant postoperative pancreatic fistula. Prevention of postpancreatectomy hemorrhage by arterial coverage with a round ligament plasty or an omental flap is controversial. This study assessed the impact of arterial coverage with an original retromesenteric omental flap on postpancreatectomy hemorrhage after pancreaticoduodenectomy., Methods: This single-center retrospective study included 812 open pancreaticoduodenectomies (2012-2021) and compared 146 procedures with arterial coverage using retromesenteric omental flap to 666 pancreaticoduodenectomies without arterial coverage. The Fistula Risk Score was calculated. The primary endpoint was a 90-day clinically relevant postpancreatectomy hemorrhage rate according to the International Study Group of Pancreatic Surgery classification., Results: There were more patients with a Fistula Risk Score ≥7 in the arterial coverage-retromesenteric omental flap group: 18 (12%) versus 48 (7%) (P < .01). Clinically relevant postpancreatectomy hemorrhage was less frequent in the arterial coverage- retromesenteric omental flap group than in the no arterial coverage group: 5 (3%) versus 66 (10%), respectively (P = .01). Clinically relevant postoperative pancreatic fistula occurred in 28 (19%) patients in the arterial coverage- retromesenteric omental flap group compared with 165 (25%) in the no arterial coverage group (P = .001). There were fewer reoperations for postpancreatectomy hemorrhage or postoperative pancreatic fistula in the arterial coverage- retromesenteric omental flap group: 1 (0.7%) versus 32 (5%) in the no arterial coverage group (P = .023). In multivariate analysis, arterial coverage with retromesenteric omental flap was an independent protective factor of clinically relevant postpancreatectomy hemorrhage (odds ratio 0.33; 95% confidence interval [0.12-0.92], P = .034) whereas postoperative pancreatic fistula of any grade (odds ratio = 10.1; 95% confidence interval: 5.1-20.3, P < .001) was predictive of this complication., Conclusion: Arterial coverage with retromesenteric omental flap can reduce rates of clinically relevant postpancreatectomy hemorrhage after pancreaticoduodenectomy. This easy and costless technique should be prospectively evaluated to confirm these results., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
61. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy.
- Author
-
Stoop TF, Oba A, Wu YHA, Beaty LE, Colborn KL, Janssen BV, Al-Musawi MH, Franco SR, Sugawara T, Franklin O, Jain A, Saiura A, Sauvanet A, Coppola A, Javed AA, Groot Koerkamp B, Miller BN, Mack CE, Hashimoto D, Caputo D, Kleive D, Sereni E, Belfiori G, Ichida H, van Dam JL, Dembinski J, Akahoshi K, Roberts KJ, Tanaka K, Labori KJ, Falconi M, House MG, Sugimoto M, Tanabe M, Gotohda N, Krohn PS, Burkhart RA, Thakkar RG, Pande R, Dokmak S, Hirano S, Burgdorf SK, Crippa S, van Roessel S, Satoi S, White SA, Hackert T, Nguyen TK, Yamamoto T, Nakamura T, Bachu V, Burns WR, Inoue Y, Takahashi Y, Ushida Y, Aslami ZV, Verbeke CS, Fariña A, He J, Wilmink JW, Messersmith W, Verheij J, Kaplan J, Schulick RD, Besselink MG, and Del Chiaro M
- Subjects
- Humans, Male, Middle Aged, Female, Aged, Neoadjuvant Therapy methods, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Treatment Outcome, Cohort Studies, Oxaliplatin therapeutic use, Pancreatectomy, Pancreatic Neoplasms drug therapy, Pancreatic Neoplasms therapy, Pancreatic Neoplasms surgery, Pancreatic Neoplasms mortality, Adenocarcinoma drug therapy, Adenocarcinoma therapy, Adenocarcinoma pathology
- Abstract
Importance: Preoperative chemo(radio)therapy is increasingly used in patients with localized pancreatic adenocarcinoma, leading to pathological complete response (pCR) in a small subset of patients. However, multicenter studies with in-depth data about pCR are lacking., Objective: To investigate the incidence, outcome, and risk factors of pCR after preoperative chemo(radio)therapy., Design, Setting, and Participants: This observational, international, multicenter cohort study assessed all consecutive patients with pathology-proven localized pancreatic adenocarcinoma who underwent resection after 2 or more cycles of chemotherapy (with or without radiotherapy) in 19 centers from 8 countries (January 1, 2010, to December 31, 2018). Data collection was performed from February 1, 2020, to April 30, 2022, and analyses from January 1, 2022, to December 31, 2023. Median follow-up was 19 months., Exposures: Preoperative chemotherapy (with or without radiotherapy) followed by resection., Main Outcomes and Measures: The incidence of pCR (defined as absence of vital tumor cells in the sampled pancreas specimen after resection), its association with OS from surgery, and factors associated with pCR. Factors associated with overall survival (OS) and pCR were investigated with Cox proportional hazards and logistic regression models, respectively., Results: Overall, 1758 patients (mean [SD] age, 64 [9] years; 879 [50.0%] male) were studied. The rate of pCR was 4.8% (n = 85), and pCR was associated with OS (hazard ratio, 0.46; 95% CI, 0.26-0.83). The 1-, 3-, and 5-year OS rates were 95%, 82%, and 63% in patients with pCR vs 80%, 46%, and 30% in patients without pCR, respectively (P < .001). Factors associated with pCR included preoperative multiagent chemotherapy other than (m)FOLFIRINOX ([modified] leucovorin calcium [folinic acid], fluorouracil, irinotecan hydrochloride, and oxaliplatin) (odds ratio [OR], 0.48; 95% CI, 0.26-0.87), preoperative conventional radiotherapy (OR, 2.03; 95% CI, 1.00-4.10), preoperative stereotactic body radiotherapy (OR, 8.91; 95% CI, 4.17-19.05), radiologic response (OR, 13.00; 95% CI, 7.02-24.08), and normal(ized) serum carbohydrate antigen 19-9 after preoperative therapy (OR, 3.76; 95% CI, 1.79-7.89)., Conclusions and Relevance: This international, retrospective cohort study found that pCR occurred in 4.8% of patients with resected localized pancreatic adenocarcinoma after preoperative chemo(radio)therapy. Although pCR does not reflect cure, it is associated with improved OS, with a doubled 5-year OS of 63% compared with 30% in patients without pCR. Factors associated with pCR related to preoperative chemo(radio)therapy regimens and anatomical and biological disease response features may have implications for treatment strategies that require validation in prospective studies because they may not universally apply to all patients with pancreatic adenocarcinoma.
- Published
- 2024
- Full Text
- View/download PDF
62. Right portal vein ligation is still relevant for left hemi-liver hypertrophy: results of a comparative study using a propensity score between right portal vein ligation and embolization.
- Author
-
Werey F, Dembinski J, Michaud A, Sabbagh C, Mauvais F, Yzet T, and Regimbeau JM
- Subjects
- Humans, Portal Vein surgery, Portal Vein pathology, Retrospective Studies, Propensity Score, Treatment Outcome, Liver surgery, Hepatectomy methods, Hypertrophy pathology, Hypertrophy surgery, Ligation, Liver Neoplasms surgery, Liver Neoplasms pathology, Embolization, Therapeutic methods
- Abstract
Background: In two-stage hepatectomy for bilobar liver metastases from colorectal cancer, future liver remnant (FLR) growth can be achieved using several techniques, such as right portal vein ligation (RPVL) or right portal vein embolization (RPVE). A few heterogeneous studies have compared these two techniques with contradictory results concerning FLR growth. The objective of this study was to compare FLR hypertrophy of the left hemi-liver after RPVL and RPVE., Study Design: This was a retrospective comparative study using a propensity score of patients who underwent RPVL or RPVE prior to major hepatectomy between January 2010 and December 2020. The endpoints were FLR growth (%) after weighting using the propensity score, which included FLR prior to surgery and the number of chemotherapy cycles. Secondary endpoints were the percentage of patients undergoing simultaneous procedures, the morbidity and mortality, the recourse to other liver hypertrophy procedures, and the number of invasive procedures for the entire oncologic program in intention-to-treat analysis., Results: Fifty-four consecutive patients were retrospectively included and analyzed, 18 in the RPVL group, and 36 in the RPVE group. The demographic characteristics were similar between the groups. After weighting, there was no significant difference between the RPVL and RPVE groups for FLR growth (%), respectively 32.5% [19.3-56.0%] and 34.5% [20.5-47.3%] (p = 0.221). There was no significant difference regarding the secondary outcomes except for the lower number of invasive procedures in RPVL group (median of 2 [2.0, 3.0] in RPVL group and 3 [3.0, 3.0] in RPVE group, p = 0.001))., Conclusion: RPVL and RPVE are both effective to provide required left hemi-liver hypertrophy before right hepatectomy. RPVL should be considered for the simultaneous treatment of liver metastases and the primary tumor., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
63. Multiplanar CT reconstructions allow optimization of the laparoscopic surgical approach for liver lesions.
- Author
-
Werey F, Allart K, Dembinski J, Yvart-Degardin J, and Regimbeau JM
- Subjects
- Humans, Retrospective Studies, Hepatectomy methods, Tomography, X-Ray Computed, Liver Neoplasms diagnostic imaging, Liver Neoplasms surgery, Laparoscopy methods
- Abstract
Purpose: Resection of hepatic lesions can be difficult and requires careful analysis of pre-operative imaging. The aim of this study is to highlight the use of multiplanar CT reconstruction in liver surgery, which helps to anticipate intra-operative technical difficulties., Methods: We retrospectively selected the imaging of several patients managed for liver lesions in specific locations: liver dome (IVa, VIII), the left lobe (intra-parenchymal, left edge), and the antero-inferior edge of segment VI. The IWATE classification was used to grade the difficulty of these resections., Results: Multiplanar analysis has made it possible to change the level of difficulty of liver resection and to anticipate intra-operative difficulties. Frontal and/or sagittal section in addition to axial sections analysis increased the IWATE score., Conclusion: Multi-planar reconstruction must be a tool used by the liver surgeon pre-operatively in order to limit intra-operative complications., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
64. Assessing the development status of intraoperative fluorescence imaging for anatomy visualisation, using the IDEAL framework.
- Author
-
Ishizawa T, McCulloch P, Stassen L, van den Bos J, Regimbeau JM, Dembinski J, Schneider-Koriath S, Boni L, Aoki T, Nishino H, Hasegawa K, Sekine Y, Chen-Yoshikawa T, Yeung T, Berber E, Kahramangil B, Bouvet M, Diana M, Kokudo N, Dip F, White K, and Rosenthal RJ
- Abstract
Objectives: Intraoperative fluorescence imaging is currently used in a variety of surgical fields for four main purposes: visualising anatomy, assessing tissue perfusion, identifying/localising cancer and mapping lymphatic systems. To establish evidence-based guidance for research and practice, understanding the state of research on fluorescence imaging in different surgical fields is needed. We evaluated the evidence on fluorescence imaging used to visualise anatomical structures using the IDEAL framework, a framework designed to describe the stages of innovation in surgery and other interventional procedures., Design: IDEAL staging based on a thorough literature review., Setting: All publications on intraoperative fluorescence imaging for visualising anatomical structures reported in PubMed through 2020 were identified for five surgical procedures: cholangiography, hepatic segmentation, lung segmentation, ureterography and parathyroid identification., Main Outcome Measures: The IDEAL stage of research evidence was determined for each of the five procedures using a previously described approach., Results: 225 articles (8427 cases) were selected for analysis. Current status of research evidence on fluorescence imaging was rated IDEAL stage 2a for ureterography and lung segmentation, IDEAL 2b for hepatic segmentation and IDEAL stage 3 for cholangiography and parathyroid identification. Enhanced tissue identification rates using fluorescence imaging relative to conventional white-light imaging have been documented for all five procedures by comparative studies including randomised controlled trials for cholangiography and parathyroid identification. Advantages of anatomy visualisation with fluorescence imaging for improving short-term and long-term postoperative outcomes also were demonstrated, especially for hepatobiliary surgery and (para)thyroidectomy. No adverse reactions associated with fluorescent agents were reported., Conclusions: Intraoperative fluorescence imaging can be used safely to enhance the identification of anatomical structures, which may lead to improved postoperative outcomes. Overviewing current research knowledge using the IDEAL framework aids in designing further studies to develop fluorescence imaging techniques into an essential intraoperative navigation tool in each surgical field., Competing Interests: Competing interests: TI (associate editor), Peter McCulloch (editor in chief), NK and RJR are editorial board members of BMJ Surgery, Interventions, & Health Technologies., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
65. Absence of abdominal drainage after surgery for secondary lower gastrointestinal tract peritonitis is a valid strategy.
- Author
-
Siembida N, Sabbagh C, Chal T, Demouron M, Rossi D, Dembinski J, and Regimbeau JM
- Subjects
- Drainage methods, Humans, Length of Stay, Lower Gastrointestinal Tract, Peritoneum, Postoperative Complications epidemiology, Postoperative Complications etiology, Retrospective Studies, Abscess, Peritonitis etiology, Peritonitis surgery
- Abstract
Background: Management of abdominal drainage after surgery for secondary lower gastrointestinal tract peritonitis (LGTP) is not a standardized procedure. A monocentric study was carried out in 2016 in our centre. (PI study) to evaluate the interest of drainage. Our objective was to revaluate, our actual use of abdominal drainage after peritonitis (PII study)., Study Design: We examined retrospectively patients who underwent surgery for secondary sub-mesocolic community-acquired peritonitis (January 2016-December 2019). Study exclusion criteria were primary peritonitis, peritoneal dialysis, nosocomial peritonitis, postoperative peritonitis, upper gastrointestinal tract peritonitis, peritonitis due to appendicitis, peritonitis requiring the implementation of Mikulicz's drain, and peritonitis in which the peritoneum was not described in the surgical report (i.e., the same criteria that the PI study which included 141 patients from January 2009 to January 2012). The primary endpoint was the rate of abdominal drainage. The secondary endpoints were the patient rate without a peritoneum description, major complications rate (Clavien ≥III), abscess rate, mortality rate and the length of stay in the non-drain group (D - ) and in the drain group (D + ) in PII study. Primary and secondary endpoints were also compared between PI and PII studies. Risk factors for post-operative abscess were also research., Results: Of the 150 patients included 33% were drained vs 84% of the 141 patients included in PI study (p < 0.001). In PII study peritoneum was described in 80.3% of patients vs 69% in PI study (NS, p = 0.06). Comparing the two groups D - and D + , no significant differences were found in major complications (respectively 45% vs 32%, p = 0.1), reoperation rate (respectively 25% vs 22%, p = 0.7), death rate (respectively 25% vs 14%; p = 0.1) and mean length of stay (respectively 12 days vs 13 days, p = 0.9). The abscess rate was significantly lower in the D - group (10% vs 30%, p = 0.002). Comparing PI and PII studies, there was no difference about major complications (35% vs 35%, p = 0.1), reoperation (16% vs 17.5%, p = 0.5), abscess rate (15% vs 8.5%, p = 0.1) and mortality (14.5% vs 17.5%, p = 0.7). The length of stay was longer in PI study than in P II (14 days vs 9 days, p = 0.03). Drainage (p = 0.005; OR = 4.357; CI [1.559-12.173]) and peritonitis type (p = 0.032; OR = 3.264; CI [1.106-9.630]) were abscess risk factors., Conclusion: This study therefore showed that drainage after surgery for LGTP may not be necessary and that, at least at the local level, surgeons seem to be inclined to discontinue it systematically. It may therefore be worthwhile to conduct a randomised control trial to establish recommendations on drainage after surgery for LGTP., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
66. The long-term outcomes of laparoscopic versus open pancreatoduodenectomy for ampullary carcinoma showed similar survival: a case-matched comparative study.
- Author
-
Dembinski J, Yoh T, Aussilhou B, Ftériche FS, Hounkonnou CPA, Hentic O, Cros J, Sauvanet A, and Dokmak S
- Subjects
- Hemorrhage surgery, Humans, Length of Stay, Pancreaticoduodenectomy methods, Postoperative Complications epidemiology, Postoperative Complications etiology, Postoperative Complications surgery, Retrospective Studies, Ampulla of Vater surgery, Laparoscopy methods, Pancreatic Neoplasms surgery
- Abstract
Background: Few studies have compared the oncological benefit of laparoscopic (LPD) and open pancreatoduodenectomy (OPD) for ampullary carcinoma. The aim of this study was to compare the oncological results of these two approaches., Methods: Between 2011 and 2020, 103 patients who underwent PD for ampullary carcinoma, including 31 LPD and 72 OPD, were retrospectively analyzed. Patients were matched on a 1:2 basis for age, sex, body mass index, American Society of Anaesthesiologists score, and preoperative biliary drainage. Short- and long-term outcomes of LPD and OPD were compared., Results: The 31 LPD were matched (1:2) to 62 OPD. LPD was associated with a shorter operative time (298 vs. 341 min, p = 0.02) than OPD and similar blood loss (361 vs. 341 mL, p = 0.747), but with more intra- and post-operative transfusions (29 vs. 8%, p = 0.008). There was no significant difference in postoperative mortality (6 vs. 2%), grades B/C postoperative pancreatic fistula (22 vs. 21%), delayed gastric emptying (23 vs. 35%), bleeding (22 vs. 11%), Clavien ≥ III morbidity (22 vs. 19%), or the length of hospital stay (26 vs. 21 days) between LPD and OPD, respectively, but there were more reinterventions (22 vs. 5%, p = 0.009). Pathological characteristics were similar for tumor size (21 vs. 22 mm), well differentiated tumors (41 vs. 38%), the number of harvested (23 vs. 26) or invaded lymph nodes (48 vs. 52%), R0 resection (84 vs. 90%), and other subtypes (T1/2, T3/4, phenotype). With a comparable mean follow-up (41 vs. 37 months, p = 0.59), there was no difference in 1-, 3-, and 5-year overall (p = 0.725) or recurrence-free survival (p = 0.155) which were (93, 74, 67% vs. 97, 79, 76%) and (85, 58, 58% vs. 90, 73, 73%), respectively., Conclusion: This study showed a similar long-term oncological results between LPD and OPD for ampullary carcinoma. However, the higher morbidity observed with LPD compared to OPD, restricting its use to experienced centers., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
67. Feasibility and Effectiveness of an Enhanced Recovery Program after Early Cholecystectomy for Acute Calculous Cholecystitis: A 2-Step Study.
- Author
-
Demouron M, Selvy M, Dembinski J, Mauvais F, Cheynel N, Slim K, Sabbagh C, and Regimbeau JM
- Subjects
- Case-Control Studies, Cholecystectomy, Feasibility Studies, Humans, Length of Stay, Treatment Outcome, Cholecystectomy, Laparoscopic, Cholecystitis, Acute surgery
- Abstract
Background: Enhanced recovery programs (ERPs) are associated with a lower morbidity rate and a shorter length of stay. The present study's objective was to determine whether an ERP is feasible and effective for patients undergoing early cholecystectomy for grade I or II acute calculous cholecystitis., Study Design: A 2-step multicenter study was performed. In the first step (the feasibility study), patients were consecutively included in a dedicated, prospective database from March 2019 until January 2020. The primary endpoint was the ERP's feasibility, evaluated in terms of the number and nature of the ERP components applied. During the second step, the ERP's effectiveness in acute calculous cholecystitis was evaluated in a case-control study. The ERP+ group comprised consecutive patients who were prospectively included from March 2019 to November 2020 and compared with a control (ERP-) group of patients extracted from the ABCAL randomized controlled trial treated between May 2010 and August 2012 and who had not participated in a dedicated ERP., Results: During the feasibility study, 101 consecutive patients entered the ERP with 17 of the 20 ERP components applied. During the effectiveness study, 209 patients (ERP+ group) were compared with 414 patients (ERP- group). The median length of stay was significantly shorter in the ERP+ group (3.1 vs 5 days; p < 0.001). There were no intergroup differences in the severe morbidity rate, mortality rate, readmission rate, and reoperation rate., Conclusions: Implementation of an ERP after early cholecystectomy for acute calculous cholecystitis appeared to be feasible, effective, and safe for patients. The ERP significantly decreased the length of stay and did not increase the morbidity rate., (Copyright © 2022 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
68. The outcome of laparoscopic pancreatoduodenectomy is improved with patient selection and the learning curve.
- Author
-
Dokmak S, Aussilhou B, Ftériche FS, Dembinski J, Romdhani C, and Sauvanet A
- Subjects
- Female, Humans, Learning Curve, Length of Stay, Pancreaticoduodenectomy methods, Patient Selection, Postoperative Complications epidemiology, Postoperative Complications etiology, Postoperative Complications surgery, Retrospective Studies, Adenocarcinoma surgery, Laparoscopy methods, Pancreatic Neoplasms pathology, Pancreatic Neoplasms surgery
- Abstract
Background: In our first experience, laparoscopic pancreatoduodenectomy (LPD) was associated with higher morbidity than open PD. Since, the surgical technique has been improved and LPD was avoided in some patients at very high risk of postoperative pancreatic fistula (POPF). We provide our most recent results., Method: Between 2011 and 2018, 130 LPD were performed and divided into 3 consecutive periods based on CUSUM analysis and compared: first period (n = 43), second period (n = 43), and third period (n = 44)., Results: In the third period of this study, LPD was more frequently performed in women (46%, 39%, 59%, p = 0.21) on dilated Wirsung duct > 3 mm (40%, 44%, 57%; p = 0.54). Intraductal papillary mucinous neoplasm (IPMN) became the primary indication (12%, 39%, 34%; p = 0.037) compared to pancreatic adenocarcinoma (35%, 16%, 16%; p = 0.004). Malignant ampulloma re-increased during the third period (30%, 9%, 20%; p = 0.052) with the amelioration of surgical technique. The operative time increased during the second period and decreased during the third period (330, 345, 270; p < 0.001) with less blood loss (300, 200, 125; p < 0.001). All complications decreased, including POPF grades B/C (44%, 28%, 20%; p = 0.017), bleeding (28%, 21%, 14%; p = 0.26), Clavien-Dindo III-IV (40%, 33%, 16%; p = 0.013), re-interventions (19%, 14%, 9%; p = 0.43), and the hospital stay (26, 19, 18; p = 0.045). Less patients with similar-sized adenocarcinoma were operated during the second period (70%, 33%, 59%; p = 0.002) with more harvested lymph nodes in the third period (21,19, 25; p = 0.031) and higher R0 resection (70%, 79%, 84%; p = 0.5). On multivariate analysis the protective factors against POPF of grades B/C were pancreatic adenocarcinoma and invasive IPMN, BMI < 22.5 kg/m
2 , and patients operated in the third period., Conclusion: This study showed that the outcome of LPD significantly improves with the learning curve and patient selection. For safe implementation and during the early learning period, LPD should be indicated in patients at lower risk of POPF., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2022
- Full Text
- View/download PDF
69. Laparoscopic Enucleation of a Deep Neuroendocrine Tumor of the Pancreatic Head Avoiding Pancreatoduodenectomy.
- Author
-
Dembinski J, Hammoud D, Lemaire A, Ftériche FS, Aussilhou B, Sauvanet A, and Dokmak S
- Subjects
- Humans, Pancreatectomy, Pancreaticoduodenectomy, Laparoscopy, Neuroendocrine Tumors surgery, Pancreatic Neoplasms surgery
- Published
- 2021
- Full Text
- View/download PDF
70. Long-term abdominal wall benefits of the laparoscopic approach in liver left lateral sectionectomy: a multicenter comparative study.
- Author
-
Darnis B, Mohkam K, Golse N, Vibert E, Cherqui D, Cauchy F, Soubrane O, Regimbeau JM, Dembinski J, Hardwigsen J, Bachelier P, Laurent C, Truant S, Millet G, Lesurtel M, Boleslawksi E, and Mabrut JY
- Subjects
- Hepatectomy, Humans, Length of Stay, Liver, Retrospective Studies, Abdominal Wall diagnostic imaging, Abdominal Wall surgery, Incisional Hernia epidemiology, Incisional Hernia etiology, Incisional Hernia prevention & control, Laparoscopy
- Abstract
Background: Laparoscopy is nowadays considered as the standard approach for hepatic left lateral sectionectomy (LLS), but its value in the prevention of incisional hernia (IH) has not been demonstrated., Methods: Between 2012 and 2017, patients undergoing laparoscopic (LLLS) or open LLS (OLLS) in 8 centers were compared. Patients undergoing a simultaneous major abdominal procedure were excluded. The incidence of IH was assessed clinically and morphologically on computed tomography (CT) using inverse probability of treatment weighting (IPTW) and multivariable regression analysis., Results: After IPTW, 84 LLLS were compared to 48 OLLS. Compared to OLLS, LLLS patients had reduced blood loss (100 [IQR: 50-200] ml vs. 150 [IQR: 50-415] ml, p = 0.023) and shorter median hospital stay (5 [IQR: 4-7] days vs. 7 [6-9] days, p < 0.001), but experienced similar rate of postoperative complications (mean comprehensive complication index: 12 ± 19 after OLLS versus 13 ± 20 after LLLS, p = 0.968). Long-term radiological screening was performed with a median follow-up of 27.4 (12.1-44.9) months. There was no difference between the two groups in terms of clinically relevant IH (10.7% [n = 9] after LLLS, 8.3% [n = 4] after OLLS, p = 0.768). The rate of IH detected on computed tomography was lower after LLLS than after OLLS (11.9% [n = 10] versus 29.2% [n = 14], p = 0.013). On multivariable analysis, the laparoscopic approach was the only independent factor influencing the risk of morphological IH (OR = 0.290 [95% CI: 0.094-0.891], p = 0.031). The 2 preferential sites for specimen extraction after LLLS were Pfannenstiel and midline incisions, with rates of IH across the extraction site of 2.3% [n = 1/44] and 23.8% [n = 5/21], respectively (p = 0.011)., Conclusion: The laparoscopic approach for LLS decreases the risk of long-term IH as evidenced on morphological examinations, with limited clinical impact. Pfannenstiel's incision should be preferred to midline incision for specimen extraction after LLLS., (© 2020. Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
71. Gastric leak after sleeve gastrectomy: risk factors for poor evolution under conservative management.
- Author
-
Rebibo L, Tricot M, Dembinski J, Dhahri A, Brazier F, and Regimbeau JM
- Subjects
- Anastomotic Leak etiology, Anastomotic Leak surgery, Conservative Treatment, France epidemiology, Gastrectomy adverse effects, Humans, Postoperative Complications etiology, Postoperative Complications surgery, Reoperation, Retrospective Studies, Risk Factors, Treatment Outcome, Laparoscopy, Obesity, Morbid surgery
- Abstract
Background: Gastric leak (GL) is the most highly feared early postoperative complication after sleeve gastrectomy (SG), with an incidence of 1% to 2%. This complication may require further surgery/endoscopy, with a risk of management failure that may require additional surgery, including total gastrectomy, leading to a risk of mortality of 0% to 9%., Objectives: Assess the impact of factors that may lead to a poorer evolution of GL., Setting: University Hospital, France, public practice., Methods: This was a retrospective, single-center study of a group of patients managed for GL after SG between November 2004 and January 2019 (n = 166). Forty-three patients were excluded. The population study was divided into 2 groups: patients with easy closing of the GL (n = 73) and patients with difficult closing of the GL or failure to heal (n = 50). Patients were allocated to 1 of 2 groups depending on the time to heal (median time of 84 days). The study's primary efficacy endpoint was to determine the risk factors for a poorer evolution of GL., Results: Among 123 patients included in this study, 103 patients had undergone primary SG (83.7%). The mean time to the appearance of GL was 15.1 days (range, 1-156 d). Seventy-four patients underwent a reoperation (60%). The mean number of endoscopies per patient was 2.7 (range, 2-7 endoscopies). The mean time to healing was 89.5 days (range, 18-386 d). There were 8 cases of healing failure (6.5%). Multivariate analysis identified body mass index (>47 kg/m
2 ), time to referral (>2 d), and serum prealbumin level (<.1 g/dL) to be independent risk factors for a poorer evolution of GL., Conclusion: Improvement of nutritional status before SG and early referral for GL could reduce the risk of delayed closure or the need for further surgery., (Copyright © 2021 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
72. Atypic large hepatic cyst with persistent elevated CA19.9 serum value: utility of intracystic CA72.4 dosage for a mini-invasive management.
- Author
-
Zurli L, Dembinski J, Robert B, and Regimbeau JM
- Subjects
- Aged, Biomarkers, Tumor, Female, Humans, Cysts diagnostic imaging, Cysts surgery, Laparoscopy, Liver Diseases diagnosis, Liver Diseases surgery
- Abstract
Simple hepatic cysts are very common, but may be difficult to differentiate from a biliary cystadenoma or cystadenocarcinoma. Because the surgical treatment if needed, such as a hepatic fenestration or resection, depends on the diagnosis, the assay of intracystic tumor markers is useful.We report the case of a 67-year-old woman with a large hepatic cyst responsible of pain and inflammation. The combination of imaging findings, serum, and intracystic fluid tumor markers [CA72.4 (carbohydrate hydrogen)] permitted to diagnose a simple hepatic cyst despite an unusual persistent elevated serum CA19.9 level. A laparoscopic cyst fenestration was proposed with an uneventful postoperative course. The pathological findings showed a simple hepatic cyst.In case of hepatic cysts, radiological findings can discriminate between benign and (pre)malignant lesions, but in case of doubtful diagnosis, the serum and intracystic tumor markers can be helpful.The use of serum or intracystic tumor marker allows to choose the correct therapeutic strategy and to use mini-invasive approach when feasible.
- Published
- 2021
- Full Text
- View/download PDF
73. Two duodenal gastrointestinal stroma tumors: Management by minimally invasive surgery and then by conservative surgery.
- Author
-
Dembinski J, Sabbagh C, Chivot C, Le Mouel JP, and Regimbeau JM
- Subjects
- Duodenum, Female, Humans, Middle Aged, Minimally Invasive Surgical Procedures, Neoplasm Recurrence, Local, Duodenal Neoplasms surgery, Gastrointestinal Stromal Tumors surgery
- Abstract
We report the case of a 48-year-old woman treated for a gastrointestinal stroma tumor of the duodenum after presenting with upper gastrointestinal bleeding. She was treated with a combination of a radiological and endoscopic approach and minimally invasive surgery. During follow-up, the patient developed a second metachronous duodenal gastrointestinal stroma tumor, distinct from a local recurrence. This tumor was treated with a conservative surgical approach., (© 2019 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and John Wiley & Sons Australia, Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
74. Are the recommendations for post-operative antibiotics in patients with grade I or II acute calculous cholecystitis being applied in clinical practice?
- Author
-
Dembinski J, Guérin O, Slim K, Navarro F, Paquet JC, Tuech JJ, Pocard M, Mauvais F, Faucheron JL, and Regimbeau JM
- Subjects
- Anti-Bacterial Agents, Cholecystectomy, Humans, Length of Stay, Postoperative Complications etiology, Postoperative Period, Retrospective Studies, Treatment Outcome, Cholecystectomy, Laparoscopic, Cholecystitis, Acute diagnosis, Cholecystitis, Acute surgery
- Abstract
Background: There is a level-1 evidence indicating that postoperative antibiotics are unnecessary following cholecystectomy for grade I or II acute calculous cholecystitis (ACC). We wanted to evaluate the applications of this recommendation in clinical practice four years after the original publication in ABCAL-participating centers., Methods: A retrospective analysis of patients operated for grade I or II ACC from January to December 2016 in ABCAL-participating centers was performed. Inclusion criteria were the same as for the ABCAL-study. The primary endpoint was the postoperative antibiotic administration rate. The secondary endpoints were postoperative outcomes., Results: Of the 283 patients included, 64% received postoperative antibiotics. Only 19% received antibiotics after POD1. The perioperative outcomes were similar between those that did or did not receive antibiotics after POD1. The median [range] length of stay was significantly shorter in patients who did not receive postoperative antibiotics (4 days [1-20]) compared to the others (6 days [1-50], p > 0.001)., Conclusion: Despite strong recommendations included in the Tokyo 2018 guidelines, the results of the ABCAL-study are poorly applied even if the absence of postoperative antibiotics has no impact on morbidity. It is important to stress that postoperative antibiotics are not necessary after cholecystectomy for grade I or II ACC., (Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
75. Validation of early drain removal after pancreatoduodenectomy based on modified fistula risk score stratification: a population-based assessment.
- Author
-
Dembinski J and Regimbeau JM
- Subjects
- Device Removal, Humans, Risk Factors, Pancreatic Fistula diagnosis, Pancreatic Fistula etiology, Pancreatic Fistula surgery, Pancreaticoduodenectomy adverse effects
- Published
- 2020
- Full Text
- View/download PDF
76. Impact of Routine 12 mm Epigastric Trocar Site Closure on Incisional Hernia After Sleeve Gastrectomy: a Prospective Before/After Study.
- Author
-
Rebibo L, Demouron M, Dembinski J, Dhahri A, Yzet T, and Regimbeau JM
- Subjects
- Adult, Aged, Case-Control Studies, Female, Hernia, Abdominal etiology, Humans, Laparoscopy adverse effects, Laparoscopy methods, Male, Middle Aged, Postoperative Period, Preoperative Period, Prospective Studies, Retrospective Studies, Risk Factors, Suture Techniques adverse effects, Suture Techniques standards, Young Adult, Abdominal Wound Closure Techniques adverse effects, Abdominal Wound Closure Techniques instrumentation, Gastrectomy adverse effects, Gastrectomy methods, Incisional Hernia etiology, Obesity, Morbid surgery, Surgical Instruments adverse effects
- Abstract
Background: Recent studies have reported trocar site hernia (TSH) rates after bariatric surgery ranging from 0 to 45.2% based on imaging assessment. The objective of this study was to evaluate the TSH rate after sleeve gastrectomy (SG) comprising routine 12 mm epigastric trocar site closure (TSC)., Material: Prospective observational study with retrospective control cohort of a group of patients undergoing primary SG with routine 12 mm epigastric TSC. The "before" group (control group) was a previously published group of patients without 12 mm epigastric TSC and the "after" group (closure group) concerned patients with routine 12 mm epigastric TSC. Primary endpoint was the TSH rate after routine epigastric TSC. Secondary endpoints were comparison of the TSH rate, TSC feasibility and causes of failure, TSC-related morbidity, evaluation of TSC time and its course, and identification of risk factors for TSH., Results: One hundred twenty-three patients were analyzed during the study period. Feasibility of epigastric TSC was 97.3% without related morbidity. Mean epigastric TSC time was 44.2 s (18-150). Epigastric TSC time was always less than 60 s after 10-15 procedures. At 1 year, 10 patients presented TSH (8.1%): epigastric in 6.5% (n = 8) cases and after open laparoscopy in 1.6% (n = 2) cases. Comparison of the two groups revealed a lower TSH rate in the closure group (8.1% vs. 17.0%; p = 0.02), due to a lower epigastric TSH rate (6.5% vs. 14.8%; p = 0.02). Routine epigastric TSC was a protective factor for TSH (p = 0.03; relative risk of 0.43)., Conclusion: Routine epigastric TSC during SG is rapid and provides effective prevention of TSH.
- Published
- 2019
- Full Text
- View/download PDF
77. Management of Uncomplicated Acute Appendicitis as Day Case Surgery: Can Outcomes of a Prospective Study Be Reproduced in Real Life?
- Author
-
Sabbagh C, Masseline L, Grelpois G, Ntouba A, Dembinski J, and Regimbeau JM
- Subjects
- Adult, Female, Humans, Intention to Treat Analysis, Length of Stay statistics & numerical data, Male, Retrospective Studies, Ambulatory Surgical Procedures, Appendectomy methods, Appendicitis surgery, Outcome and Process Assessment, Health Care
- Abstract
Background: The feasibility of day case surgery (DCS) appendectomy for uncomplicated acute appendicitis (UCAA) was evaluated by the prospective AppendAmbu (Feasibility of Outpatient Appendectomy for Acute Appendicitis) study (ClinicalTrials.gov ID NCT01839435). The aim of this study was to evaluate the real-life feasibility of DCS for UCAA., Study Design: This single-center, retrospective, non-interventional study was conducted after the AppendAmbu study and included UCAA only. The primary end point was DCS success rate (ie length of stay <12 hours) in the intention-to-treat population (all patients with UCAA) and in the per-protocol population (population with UCAA and no preoperative and intraoperative exclusion criteria). The secondary end points were to determine the DCS quality criteria to evaluate and compare the morbidity and mortality of DCS and conventional hospitalization for UCAA (Clavien, Comprehensive Complication Index) and to externally validate the St Antoine criteria for the selection of patients for DCS., Results: From January 2016 to September 2017, two hundred and ninety-six patients underwent operations for acute appendicitis. The proportion of patients with successful DCS management was 27% in the intention-to-treat population and 95% in the per-protocol population. The unplanned consultation rate was 15%, the unplanned hospitalization rate was 4%, and the unplanned reoperation rate was 0%. The postoperative morbidity of patients managed by DCS was not different from that of patients managed in conventional hospitalization. The DCS success rate was 0%, with a St Antoine score of 0, and 80% of patients had a St Antoine score of 5 (p < 0.0001)., Conclusions: Day case surgery constitutes progress in surgery as a result of enhanced recovery programs. It avoids unnecessary prolonged hospitalization., (Copyright © 2019. Published by Elsevier Inc.)
- Published
- 2019
- Full Text
- View/download PDF
78. Portal vein variants associated with right hepatectomy: An analysis of abdominal CT angiography with 3D reconstruction.
- Author
-
Clipet F, Rebibo L, Dembinski J, Yzet T, Vilgrain V, and Regimbeau JM
- Subjects
- Aged, Constriction, Female, Humans, Liver diagnostic imaging, Male, Portal Vein diagnostic imaging, Retrospective Studies, Computed Tomography Angiography methods, Hepatectomy adverse effects, Imaging, Three-Dimensional methods, Liver anatomy & histology, Portal Vein anatomy & histology
- Abstract
Glissonian approach has been described as a selective vascular clamping procedure during hepatectomy based on external anatomical landmarks. Anatomical variations of the right Glissonian pedicle have been identified with an increased risk of clamping failure during Glissonian approach. The objective of this study was to characterize the anatomical variations of the right Glissonian pedicle at risk of clamping failure during right hepatectomy. This was a retrospective analysis of abdominal multiphasic CT and routine 3D reconstruction (n = 346). Anatomical variations at risk of clamping failure were Types 1 to 3 (Madoff's classification) and an angle of less than 50° between the portal vein and the left portal vein. Primary objective was the risk of right Glissonian pedicle clamping failure. Secondary objectives were the rate of normal anatomy, the rate of variations, and the rate of incomplete or extended clamping. Normal anatomy was found in 245 patients (71%). Anatomical variations were as follows: Type 1: 11%, Type 2: 17%, Type 3: 0.8%, Type 4: 0%. Angle variation less than 50° was observed in 4.5%. The risk of selective clamping failure was 34%. Extension of clamping was observed in 16%, while incomplete clamping was observed in 17.8%. Failure of right Glissonian pedicle clamping was predictable in 34% of cases while 71% of patients presented normal portal vein anatomy. Clin. Anat. 32:328-336, 2019. © 2018 Wiley Periodicals, Inc., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
79. [Oseltamivir in pregnancy, lactation and neonatal period--comparison of international recommendations].
- Author
-
Dembinski J
- Subjects
- Female, Humans, Infant, Newborn, Pregnancy, Influenza A Virus, H1N1 Subtype, Influenza, Human prevention & control, Lactation drug effects, Oseltamivir administration & dosage, Oseltamivir adverse effects, Postnatal Care standards, Pregnancy Complications, Infectious prevention & control
- Abstract
Background: In the current influenza A (H1N1) pandemia, data on neonatal and maternal Oseltamivir chemoprophylaxis and treatment are limited. Recommendations of national and international health authorities do not compensate for a lack of controlled studies on pharmacokinetics and safety. However, the level of consent may contribute to individual clinical decisions., Methods: We have reviewed online recommendations by health authorities in the context of the current literature., Results: Given the limited database, there is a high level of consent among recommendations issued by health authorities regarding treatment with Oseltamivir and breast-feeding., Discussion: The majority of recommendations do not regard treatment with Oseltamivir as a contraindication to breast-feeding. Antiviral chemoprophylaxis of influenza A (H1N1) infection in preterm infants is not recommended due to the lack of data on its pharmacokinetics and safety., Conclusion: Variable recommendations have been issued regarding the choice of neuraminidase inhibitors in pregnancy. Additional information on the pharmacokinetics and safety of neuraminidase inhibitors for breast-feeding mothers and neonates is essential in order to address potential future pandemics.
- Published
- 2010
- Full Text
- View/download PDF
80. Diagnosis of in utero Parvovirus B19 infection and maternal immune response - the relevance of linear epitopes and advanced serologic testing.
- Author
-
Dembinski J
- Abstract
Importance of the Field: Parvovirus B19 (B19V) infection in utero causing fetal anemia and non-immune hydrops fetalis (NIHF) is a potentially life-threatening event for the fetus. Postexpositional non-invasive diagnosis is based on maternal IgG/IgM response and detection of viral genome in maternal blood. Serologic testing directs prenatal follow-up. Fetal infection is confirmed by polymerase chain reaction or in situ hybridization in fetal blood and/or amniotic fluid cells. The performance of serologic tests is significant in order to direct pre- and perinatal care at rational use of resources. Timing of diagnostic procedures and knowledge of the time course of infection in pregnant, asymptomatic women are critical. IgM negative testing in the presence of prolonged viremia may complicate individual risk analysis in pregnancy. Recently, advanced IgG avidity assays and epitope-type specific assays (IgG ETS EIA) have been re-evaluated., Areas Covered in This Review: Epidemiology, clinical relevance and management of B19V infection in pregnancy. A review of the current literature (November 1984 - May 2009) and evaluation of current information on performance and predictive value of molecular and VP1/VP2 antigen-based IgG tests directed at the diagnosis of materno-fetal B19V infection and detection of past immunity. New aspects of B19V-associated fetal disease other than anemia/NIHF are also covered., What the Reader Will Gain: An overview of immunology and clinical relevance of B19V infection in pregnancy, of the potential value of advanced serologic testing and fields of future research., Take Home Message: In the absence of a commercially available vaccine, serologic tests remain important tools in individual risk analysis of pregnant women exposed to B19V. Sequential application of IgG avidity and IgG ETS EIAs may improve risk stratification and timing of invasive testing in B19V-exposed pregnancies, in particular with IgM-negativity and/or persistent DNAemia. Prospective evaluation of these test systems correlated to fetal outcome in order to reduce fetal morbidity and mortality as well as the overall burden of disease of B19V with regard to fetal malformation may be subject to future research.
- Published
- 2010
- Full Text
- View/download PDF
81. [Unilateral pulmonary agenesis, aplasia and dysplasia].
- Author
-
Dembinski J, Kroll M, Lewin M, and Winkler P
- Subjects
- Female, Humans, Infant, Newborn, Male, Abnormalities, Multiple diagnosis, Abnormalities, Multiple therapy, Lung abnormalities
- Abstract
Unilateral pulmonary anomalies are rare events of unknown etiology and large clinical variability. Neonatal history does not allow for a reliable prognosis. Interdisciplinary mangament includes prenatal diagnostics and obstetrics, genetics, neonatology, pediatric cardiology and surgery as well as pediatric orthopedics. Neonatal history and long-term follow-up in three patients are presented here including a discussion of prenatal diagnostics and the embryo-genetic basics of lung development. In three term neonates the diagnoses of unilateral pulmonary agenesis, aplasia and dysplasia, respectively, were based on angiography, MRI and bronchoscopy. Neonatal presentation and long-term consequences were studied in the context of the current literature. Neonatal complications ranged from mild repiratory distress to pulmonary failure requiring mechanical ventilation. One patient developed scoliosis on long-term follow-up. Cardiac failure or pulmonary hypertension did not occur during follow-up, in one case lung malformation was accompanied by VACTER-association. Unilateral lung malformation is frequently associated with other, singular or complex anomalies (e.g., renal and vascular). A possible relationship to disrupted regulation of embryo-genetic factors such as T-BOX genes, PITX2 and growth factors ( FGF10), which regulate ASYMMETRICAL pulmonary morphogenesis is discussed. Disruptive unilateral pulmonary malformations may serve as a model for embryological lung development and other anomalies (e.g., congenital diaphragmatic hernia, unilateral hypoplasia and CCAM). Prenatal diagnosis is characterized by unilateral hyperechogenicity of the affected lung. Neonatal presentation is determined by mediastinal shift which may be corrected by tissue-expander implantation. Associated anomalies require cytogenetic analysis and sequencing of currently known mutations. Long-term follow-up by echocardiography and pulmonary function testing is mandatory in these patients.
- Published
- 2009
- Full Text
- View/download PDF
82. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.
- Author
-
Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, and Marini F
- Subjects
- Animals, Extracellular Matrix metabolism, Fibroblasts, Humans, Mesenchymal Stem Cell Transplantation methods, Neoplasms blood supply, Neoplasms metabolism, Genetic Therapy methods, Mesenchymal Stem Cells metabolism, Neoplasms therapy
- Abstract
Recent evidence suggests that mesenchymal stem cells (MSC) selectively home to tumors, where they contribute to the formation of tumor-associated stroma. This effect can be opposed by genetically modifying MSC to produce high levels of anti-cancer agents that blunt tumor growth kinetics and inhibit the growth of tumors in situ. In this review article, we describe the biological properties of MSC within the tumor microenvironment and discuss the potential use of MSC and other bone marrow-derived cell populations as delivery vehicles for antitumor proteins.
- Published
- 2007
- Full Text
- View/download PDF
83. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
- Author
-
Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, and Lang FF
- Subjects
- Animals, Brain Neoplasms pathology, Cell Movement physiology, Genetic Engineering, Glioblastoma pathology, Humans, Interferon-beta genetics, Interferon-beta physiology, Male, Mesenchymal Stem Cells cytology, Mice, Mice, Inbred C57BL, Mice, Nude, Xenograft Model Antitumor Assays, Bone Marrow Transplantation, Brain Neoplasms therapy, Glioblastoma therapy, Mesenchymal Stem Cells physiology
- Abstract
The poor survival of patients with human malignant gliomas relates partly to the inability to deliver therapeutic agents to the tumor. Because it has been suggested that circulating bone marrow-derived stem cells can be recruited into solid organs in response to tissue stresses, we hypothesized that human bone marrow-derived mesenchymal stem cells (hMSC) may have a tropism for brain tumors and thus could be used as delivery vehicles for glioma therapy. To test this, we isolated hMSCs from bone marrow of normal volunteers, fluorescently labeled the cells, and injected them into the carotid artery of mice bearing human glioma intracranial xenografts (U87, U251, and LN229). hMSCs were seen exclusively within the brain tumors regardless of whether the cells were injected into the ipsilateral or contralateral carotid artery. In contrast, intracarotid injections of fibroblasts or U87 glioma cells resulted in widespread distribution of delivered cells without tumor specificity. To assess the potential of hMSCs to track human gliomas, we injected hMSCs directly into the cerebral hemisphere opposite an established human glioma and showed that the hMSCs were capable of migrating into the xenograft in vivo. Likewise, in vitro Matrigel invasion assays showed that conditioned medium from gliomas, but not from fibroblasts or astrocytes, supported the migration of hMSCs and that platelet-derived growth factor, epidermal growth factor, or stromal cell-derived factor-1alpha, but not basic fibroblast growth factor or vascular endothelial growth factor, enhanced hMSC migration. To test the potential of hMSCs to deliver a therapeutic agent, hMSCs were engineered to release IFN-beta (hMSC-IFN-beta). In vitro coculture and Transwell experiments showed the efficacy of hMSC-IFN-beta against human gliomas. In vivo experiments showed that treatment of human U87 intracranial glioma xenografts with hMSC-IFN-beta significantly increase animal survival compared with controls (P < 0.05). We conclude that hMSCs can integrate into human gliomas after intravascular or local delivery, that this engraftment may be mediated by growth factors, and that this tropism of hMSCs for human gliomas can be exploited to therapeutic advantage.
- Published
- 2005
- Full Text
- View/download PDF
84. Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10.
- Author
-
Zittermann A, Dembinski J, and Stehle P
- Subjects
- 25-Hydroxyvitamin D 2 blood, Calcifediol blood, Calcium blood, Disease Susceptibility immunology, Germany, Humans, Immunoglobulin E blood, Infant, Infant, Newborn blood, Seasons, Fetal Blood chemistry, Infant, Newborn immunology, Interleukin-10 blood, Vitamin D analogs & derivatives, Vitamin D blood
- Abstract
The cytokine interleukin-10 (IL-10) plays a pivotal regulatory role in tolerizing exogenous antigens. Experimental data indicate that low cellular availability of the vitamin D hormone 1,25-dihydroxyvitamin D [1,25(OH)2D] results in a down-regulation of IL-10 concentrations. The tissue production of an adequate amount of 1,25(OH)2D depends on a high circulating 25-hydroxyvitamin D (25-OHD) level. The present study was thus aimed at evaluating the associations between season of birth, vitamin D status, and the allergy risk markers IL-10 and total immunoglobulin (IgE) in newborns. Cord blood was obtained from 49 infants born during the summer half year (mid-April to mid-October, geographic latitude 51 degrees N) and from 47 infants born during the winter half year (mid-October to mid-April, geographic latitude of 51 degrees N). Serum levels of 25-OHD were 99% higher, and IL-10 levels were 43% higher in the summer half year compared with the winter half year (p < 0.001 and p = 0.018). Moreover, the ratio of IL-10 to total IgE was 124% higher in the summer half year compared with the winter half year (p = 0.039). Serum levels of 25-OHD were correlated with IL-10 levels (r = +0.22; p < 0.05). Mothers' age, gestational ages, birth weights and serum 1,25(OH)2D levels did not differ between study groups. We conclude that the low vitamin D status of infants born in winter may at least in part adversely affect biomarkers of allergy risk., (Copyright 2004 Blackwell Munksgaard)
- Published
- 2004
- Full Text
- View/download PDF
85. Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy.
- Author
-
Rohde A, Dembinski J, and Dorn C
- Subjects
- Adult, Cesarean Section, Female, Humans, Infusions, Intravenous, Mirtazapine, Pregnancy, Pregnancy Trimester, Second, Abortion, Induced psychology, Antidepressive Agents, Tricyclic administration & dosage, Hyperemesis Gravidarum drug therapy, Mianserin administration & dosage, Mianserin analogs & derivatives, Twins
- Abstract
Case Report: We present the case of a 25-year-old woman with treatment resistant hyperemesis gravidarum in the 15th week with a 13 kg loss of body weight. When the patient asked for termination of the pregnancy because of the unbearable symptoms, treatment with intravenous mirtazapine (Remergil) was started., Results: Nausea and vomiting disappeared within hours, pregnancy termination was no longer desired. The patient was discharged two weeks later in good health and at 36 weeks gestation a cesarean section was performed. Post partum evaluation as well as 6-month post-partum revealed no dysmorphology or laboratory abnormalities in the children.
- Published
- 2003
- Full Text
- View/download PDF
86. Neonatal inflammatory response.
- Author
-
Dembinski J, Behrendt D, and Bartmann P
- Subjects
- Humans, Infant, Newborn, Reproducibility of Results, Cytokines blood, Inflammation blood, Specimen Handling
- Published
- 2003
- Full Text
- View/download PDF
87. Modulation of pro- and anti-inflammatory cytokine production in very preterm infants.
- Author
-
Dembinski J, Behrendt D, Martini R, Heep A, and Bartmann P
- Subjects
- Cytokines blood, Gestational Age, Granulocyte Colony-Stimulating Factor blood, Granulocyte Colony-Stimulating Factor metabolism, Humans, Infant, Infant, Newborn, Infant, Premature blood, Inflammation blood, Inflammation Mediators blood, Interferon-gamma blood, Interferon-gamma metabolism, Interleukin-1 blood, Interleukin-1 metabolism, Interleukin-10 blood, Interleukin-10 metabolism, Interleukin-6 blood, Interleukin-6 metabolism, Interleukin-8 blood, Interleukin-8 metabolism, Tumor Necrosis Factor-alpha analysis, Tumor Necrosis Factor-alpha metabolism, Cytokines metabolism, Infant, Premature metabolism, Inflammation metabolism, Inflammation Mediators metabolism
- Abstract
Background: In premature infants, outcome of infection-associated complications is heterogeneous despite advances in antibiotic treatment and diagnosis. Information on the immune response in preterm infants is limited. Immune modulatory strategies require detailed analysis of mediators and their kinetics., Objective: To determine the kinetics of IL-1beta, TNFalpha, IL-6, IL-8, IL-10, gammaINF and G-CSF in preterm and term infants in an ex vivo cord blood culture (CBC) endotoxin model., Design and Methods: Cord blood of 25 infants was obtained immediately after birth from the fetal side of the placenta and incubated in culture medium (RPMI 1640) in the presence or absence of 500 pg/ml lipopolysaccharide (LPS) for 48h. TNFalpha, IL-1beta, IL-6 and IL-8 were measured by sequential immunometric assay (IMMULITE, DPC Biermann, Germany); IL-10 (Milenia Biotec, Bad Nauheim, Germany), gammaINF (Diaclone, Besancon, France) and G-CSF (R & D Systems, Wiesbaden, Germany) were determined by ELISA in supernatants at 0, 4, 8, 12, 24 and 48h. Infants were stratified into three gestational age groups (< or =32 weeks, 33-36 weeks, > or =37 weeks). Variations between the groups were first analyzed for significance by Kruskal-Wallis test and pairs were compared by Mann-Whitney-U test. Effects of gestational age, leucocyte count, hematocrit and frequency of antenatal steroid exposure were tested by linear regression analysis. To correct a possible impact of variable, WBC count, cytokine levels were adjusted according to individual leucocyte numbers., Results: LPS-stimulated maximum levels of IL-6, IL-1beta,TNFalpha and G-CSF in CBC were significantly lower in very preterm infants compared to more advanced gestational age groups. After adjusting the cytokine levels for 10(5) leucocytes, a significant effect of gestational age on IL-6 and G-CSF production (p<0.05) was detected. A non-significant trend towards reduced cytokine levels was observed following multiple antenatal steroid exposures. IL-10:TNFalpha ratio increased in very preterm neonates when compared with the advanced gestational age, although the increase was not significant., Conclusions: Pro-inflammatory cytokine activity in CBC correlates with gestational age, whereas IL-10 does not. Although ex vivo synthesis of IL-1beta, TNFalpha, IL-6, G-CSF in CBC depends in part on leucocyte numbers, IL-6 and G-CSF synthesis appeared to be related to immaturity. Non-significant effects of multiple antenatal steroid exposure and increased IL-10:TNFalpha ratio in preterm neonates, observed in a small sample size, warrant further investigation.
- Published
- 2003
- Full Text
- View/download PDF
88. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops.
- Author
-
Dembinski J, Haverkamp F, Maara H, Hansmann M, Eis-Hübinger AM, and Bartmann P
- Subjects
- Child, Female, Follow-Up Studies, Gestational Age, Humans, Intelligence, Male, Multivariate Analysis, Pregnancy, Prognosis, Retrospective Studies, Blood Transfusion, Intrauterine, Child Development, Erythrocyte Transfusion methods, Hydrops Fetalis virology, Parvoviridae Infections therapy, Parvovirus B19, Human, Pregnancy Complications, Infectious therapy
- Abstract
Objective: To assess long term neurodevelopmental outcome of children after intrauterine intravascular red cell transfusion (JUT) for Parvovirus B19-induced fetal hydrops., Design: Data of study children were investigated retrospectively. Neurodevelopmental evaluation was performed by appropriate standard tests (Griffiths, Snijders-Oomen, Kaufmann Assessment Battery for Children tests)., Setting: Tertiary care university teaching hospital., Sample: Twenty children who had Parvovirus-induced fetal hydrops and intrauterine transfusion of packed red blood cells (IUT)., Methods: Retrospective chart analysis and standard neurodevelopmental testing., Main Outcome Measures: Developmental quotient (DQ) and intelligence quotient (IQ) according to the age at testing., Results: Twenty survivors of Parvovirus B19-induced fetal hydrops successfully treated by IUT were followed until 13 months to nine years of age. On clinical follow up, no neurologic sequelae were evident. Neurodevelopmental scores of all children ranged within two standard deviations of a normal population (median 101, range 86-116) and exceeded one standard deviation in three children. There was no significant neurodevelopmental delay., Conclusion: Children having survived successful IUT for Parvovirus B19-induced fetal anaemia and hydrops have a good neurodevelopmental prognosis. Our results support the use of IUT for correction of Parvovirus B19-induced fetal anaemia and subsequent hydrops.
- Published
- 2002
- Full Text
- View/download PDF
89. Cell-associated interleukin-8 in cord blood of term and preterm infants.
- Author
-
Dembinski J, Behrendt D, Heep A, Dorn C, Reinsberg J, and Bartmann P
- Subjects
- Cesarean Section, Female, Humans, Infant, Newborn, Infant, Premature blood, Labor, Obstetric immunology, Pregnancy, Stress, Physiological blood, Stress, Physiological immunology, Fetal Blood immunology, Infant, Premature immunology, Interleukin-8 blood
- Abstract
To assess the effect of gestational age and labor on the interleukin-8 (IL-8) concentration in whole cord blood and serum, IL-8 levels were determined simultaneously in cord blood serum and lysate in 134 infants. Following the elimination of some of the samples due to exclusion criteria, the data for 99 uninfected infants (71 term and 28 preterm) and 9 infants with neonatal bacterial infection delivered either vaginally or by elective or emergency cesarean section were analyzed. The effects of labor and gestational age were tested by analysis of variance. IL-8 was not detectable in the serum of 25 infants, whereas IL-8 levels in whole blood were measurable in all of the samples. The median IL-8 conncentrations in whole cord blood lysate were 106 pg/ml (range, 20 to 415 pg/ml) in preterm infants and 176 pg/ml (range, 34 to 1,667 pg/ml) in term infants. In contrast to the IL-8 levels in serum, IL-8 levels in whole blood were reduced after ECS. Gestational age had no independent effect on the IL-8 concentrations in either serum or whole blood; these concentrations increased in infected infants after labor. We conclude that the neonatal proinflammatory response to labor stress was more evident in the concentrations of IL-8 in whole blood than in serum. The levels of IL-8 in whole-blood lysate reflect proinflammatory stimulation in neonates and may be a useful diagnostic tool for the early diagnosis of neonatal infection.
- Published
- 2002
- Full Text
- View/download PDF
90. Determination of total interleukin-8 in whole blood after cell lysis.
- Author
-
Reinsberg J, Dembinski J, Dorn C, Behrendt D, Bartmann P, and van Der Ven H
- Subjects
- Adult, Age Factors, Amniotic Fluid microbiology, Blood Specimen Collection, Female, Humans, Immunoassay, Male, Middle Aged, Pregnancy, Pregnancy Complications, Infectious blood, Sensitivity and Specificity, Sex Factors, Syndrome, Interleukin-8 blood
- Abstract
Background: It has been shown that a high percentage of interleukin-8 (IL-8) in blood is cell associated. Recently, a simple method for determination of cell-associated IL-8 in whole blood after cell lysis has been described. The purpose of this study was to evaluate this method, to examine the influence of preanalytic sample handling, and to establish the concentration range of total IL-8 and its relation to age and sex in healthy subjects., Methods: Total IL-8 content of whole blood was determined after lysing blood cells with Milenia((R)) cell lysis solution. IL-8 in the resulting blood lysate was measured with the IMMULITE((R)) IL-8 immunoassay., Results: When freshly drawn blood was stored up to 48 h on ice, no significant changes in total IL-8 were measured in the subsequently prepared lysate, whereas with storage at room temperature, total IL-8 increased after 3 h from 94 +/- 13 ng/L to 114 +/- 16 ng/L (n = 10). In lysate stored for 48 h at 4 degrees C, marginal changes of the IL-8 concentration were noted, with storage at room temperature, only 76% +/- 5% (n = 12) of initial concentration was recovered. From lysate frozen at -20 and -80 degrees C, respectively, 84% +/- 4% and 93% +/- 2% of initial IL-8 was recovered after 70 days (n = 10). IL-8 was measured with comparable precision in plasma (CV, 3. 2-4.2%) and blood lysate (CV, 3.7-4.1%). When plasma was diluted with cell lysis solution, a slightly overestimated recovery (125% +/- 3%) was observed; for lysate specimens with a cell lysis solution content >/=75%, the recovery after dilution was 98% +/- 2%. In lysate prepared from 12 blood samples with exogenous IL-8 added, IL-8 recovery was 104% +/- 2% (recovery from plasma <35%). The median total IL-8 in blood lysates from 103 healthy subjects (22-61 years) was 83 ng/L of blood (2.5-97.5 percentile range, 49-202 ng/L of blood). In females but not in males, total IL-8 increased significantly with advancing age (P: <0.002). We found grossly increased total IL-8 in six pregnant women with amniotic infection syndrome., Conclusions: The evaluated method allows the assessment of total IL-8 in blood with good performance when appropriate conditions of sample pretreatment are considered. The values in healthy volunteers all were above the detection limit of the IL-8 assay; therefore, slight changes of total IL-8 could be noted. Thus, the present method is a suitable tool to study the diagnostic relevance of total IL-8 in blood.
- Published
- 2000
91. Production of monoclonal antibodies against recombinant human interferon-gamma: screening of hybridomas without purified antigen.
- Author
-
Alfa MJ, Dembinski JJ, and Jay FT
- Subjects
- Animals, Antibodies, Monoclonal immunology, Humans, Mice, Neutralization Tests, Predictive Value of Tests, Rabbits, Recombinant Proteins immunology, Antibodies, Monoclonal isolation & purification, Enzyme-Linked Immunosorbent Assay methods, Hybridomas immunology, Interferon-gamma immunology
- Abstract
A panel of mouse monoclonal antibodies (MAbs) against the recombinant human gamma interferon (HuIFN-gamma) has been produced for the study of the structure-function relationships of this important lymphokine. Enzyme linked immunosorbent assay (ELISA) is the current method of choice to screen hybridomas for specific MAb production. The purity of the antigen used for screening dictates the specificity of the ELISA. As often is the case in many systems, adequately purified biologically active HuIFN-gamma was not readily available for this purpose. A sandwich ELISA which allowed the use of unpurified HuIFN-gamma for hybridoma screening was developed. A rabbit antiserum against the denatured HuIFN-gamma purified by SDS-PAGE was prepared and the nonspecific binding activity was removed by adsorption to control cell proteins immobilized on Sepharose. The adsorbed immunoglobulin fraction was bound to the ELISA plate: (i) to trap HuIFN-gamma specifically from the whole cell lysate, thus providing specificity for MAb detection, and (ii) to avoid direct adsorption of the HuIFN-gamma to the ELISA plate because others have found that this prevented detection of neutralizing MAb. The sandwich ELISA detected both neutralizing and non-neutralizing MAbs with relatively low false positive reactions. This approach to the development of an ELISA method to screen hybridomas without purified antigen should be applicable to the production of MAbs to other proteins.
- Published
- 1987
- Full Text
- View/download PDF
92. The pharmacology of (minus)-3-hydroxy-N-cyclopropylmethylmorphinan (cyclorphan).
- Author
-
Harris LS, Pierson AK, Dembinski JR, and Dewey WL
- Subjects
- Animals, Blood Pressure drug effects, Cats, Cyclazocine pharmacology, Dogs, Doxapram pharmacology, Heart Rate drug effects, Meperidine pharmacology, Morphinans pharmacology, Nalorphine pharmacology, Rats, Reflex, Stretch, Respiration drug effects, Analgesics pharmacology, Narcotic Antagonists pharmacology
- Published
- 1967
93. ALPHA-BENZYLTETRAHYDROFURFURYLAMINES--A NEW SERIES OF PSYCHOMOTOR STIMULANTS. III. THE PHARMACOLOGY OF D-THREO ALPHA-BENZYL-N-ETHYLTETRAHYDROFURFURYLAMINE (ZYLOFURAMINE).
- Author
-
HARRIS LS, CLARKE RL, and DEMBINSKI JR
- Subjects
- Animals, Cats, Dogs, Mice, Appetite, Behavior, Animal, Blood Pressure, Body Temperature, Central Nervous System, Central Nervous System Stimulants, Chlorpromazine, Dextroamphetamine, Electrocardiography, Electroencephalography, Haplorhini, Pharmacology, Research, Toxicology
- Published
- 1963
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.